Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.

Autor: Stacchiotti S; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori (INT), 20133 Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it., Maria Frezza A; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori (INT), 20133 Milan, Italy., Demetri GD; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Blay JY; Department of Medicine, Centre Léon Bérard, Université Claude Bernard Lyon I, Unicancer, 69008 Lyon, France., Bajpai J; Medical Oncology Department, Tata Memorial Centre, Homi Bhabha National Institute, 400012 Mumbai, India., Baldi GG; Department of Medical Oncology, Ospedale Santo Stefano, 59100, Prato, Italy., Baldini EH; Department of Radiation Oncology, Dana-Farber Cancer Institute/ Brigham and Women's Hospital, Boston 02215, MA, USA., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, TX, USA., Bonvalot S; Department of Surgical Oncology, Institut Curie, Université Paris Sciences et Lettres, 75005, France., Bovée JVMG; Departmen of Pathology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands., Callegaro D; Department of Surgery, INT, 20133 Milan, Italy., Casali PG; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori (INT), 20133 Milan, Italy., D'Angelo SP; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 10065, New York, NY, USA., Davis EJ; Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Dei Tos AP; Department of Pathology, Azienda Ospedaliera Università Padova, 35129, Padova, Italy., Demicco EG; Department of Laboratory Medicine and Pathobiology, University of Toronto & Pathology and Laboratory Medicine Mount Sinai Hospital, ON M5G 1X5, Toronto, Canada., Desai J; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne VIC 3000, Australia., Dileo P; Soft tissue and bone sarcoma service, University College Hospital, UCLH NHS Trust, NW1 2BU, London, United Kingdom., Eriksson M; Department of Oncology, Skåne University Hospital, and Lund University, 222 42, Lund, Sweden., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands., George S; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Gladdy RA; Mount Sinai Hospital, Princess Margaret Hospital, University of Toronto, ON M5G 1X5, Toronto, ON, Canada., Gounder MM; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 10065, New York, NY, USA., Gupta AA; The Hospital for Sick Children and Princess Margaret Cancer Center, University of Toronto, ON M5G 2C1, Toronto, Canada., Haas R; Department of Radiotherapy, the Netherlands Cancer Institute, 1066 CX, Amsterdam and the Leiden University Medical Center, 2333 ZA, Leiden, The Netherlands., Hayes A; Department of Surgery, the Royal Marsden NHS Foundation Trust, SW3 6JJ, London, United Kingdom., Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Center, Medical Faculty Mannheim, University of Heidelberg, 69117 Heidelberg, Germany., Jones KB; Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah, UT 84112, Salt Lake City, USA., Jones RL; Sarcoma Unit, the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, SW3 6JJ, London, United Kingdom., Kasper B; Sarcoma Unit, Mannheim Cancer Center (MCC), Mannheim University Medical Center, University of Heidelberg, 68167 Mannheim, Germany., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Kirsch DG; Department of Radiation Oncology, Duke University Medical Center, NC 27710 Durham, USA., Kleinerman ES; Division of Pediatrics, University of Texas M.D. Anderson Cancer Center, 77030 Huston, TX, USA., Le Cesne A; Medical Oncology, Insitut Gustave Roussy, 94805 Villejuif, Ile-de-France, France., Maestro R; Unit of Oncogenetics and Functional Oncogenomics, 33081 Aviano, Italy., Martin Broto J; Medical Oncology Department, University Hospital Fundacion Jimenez Diaz, University Hospital General de Villalba and Instituto de Investigacion Sanitaria FJD, 28040 Madrid, Spain., Maki RG; Abramson Cancer Center, University of Pennsylvania, 19104 Philadelphia, PA, USA., Miah AB; Department of Radiation Therapy, the Royal Marsden NHS Foundation Trust, SW3 6JJ, London, United Kingdom., Palmerini E; Osteoncology, Soft Tissue and Bone Sarcoma and Innovative Therapy Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, TX, USA., Raut CP; Department of Surgery, Brigham and Women's Hospital, Center for Sarcoma and Bone Oncology, DFCC, Harvard Medical School, Boston 02215, MA, USA., Razak ARA; Princess Margaret Cancer Center, ON M5G 2C1, Toronto, Canada., Reed DR; Department of Individualized Cancer Management, Moffitt Cancer Center, FL 33612, Tampa, FL, USA., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 00-001, Warsaw, Poland., Sanfilippo RG; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori (INT), 20133 Milan, Italy., Sbaraglia M; Department of Pathology, Azienda Ospedaliera Università Padova, 35129, Padova, Italy., Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, MA 02215, Boston, MA, USA., Strauss DC; Department of Surgery, The Royal Marsden Hospital and The Institute of Cancer Research, SW3 6JJ, London, the United Kingdom of Great Britain and Northern Ireland., Strauss SJ; Soft tissue and bone sarcoma service, University College Hospital, UCLH NHS Trust, NW1 2BU, London, United Kingdom., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, 10065, New York, NY, USA., Thomas DM; Garvan Institute of Medical Research, NSW 2010, Sydney, Australia., Trama A; Department of Research, Evaluative Epidemiology Unit, INT, 20133 Milan, Italy., Trent JC; Sylvester Comprehensive Cancer Center, University of Miami, 33136 Miami, FL, USA., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., van Houdt WJ; Department of Surgical Oncology, the Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., von Mehren M; Department of Hematology and Oncology, Fox Chase Cancer Center, 19111 Philadelphia, PA, USA., Wilky BA; Department of Medical Oncology, University of Colorado Cancer Center, 80045 Aurora, CO, USA., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, MA 02215, Boston, MA, USA., Gronchi A; Department of Surgery, INT, 20133 Milan, Italy., Miceli R; Unit of Clinical Epidemiology and Trial Organization, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Wagner AJ; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.

Publikováno v: Cancer treatment reviews [Cancer Treat Rev] 2022 Nov; Vol. 110, pp. 102455. Date of Electronic Publication: 2022 Aug 18.

Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.

Autor: Stacchiotti S; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Frezza AM; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Blay JY; Leon Berard Center, Claude Bernard University Lyon 1, UNICANCER Hospital Network, Lyon, France., Baldini EH; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Bonvalot S; Department of Surgical Oncology, Curie Institute, University of Paris-Sciences and Letters, Paris, France., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands., Callegaro D; Department of Surgery, National Cancer Institute of Milan, Milan, Italy., Casali PG; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Chiang RC; Taiwan Cancer Registry Center, Taipei, Taiwan.; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan., Demetri GD; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts., Demicco EG; Department of Pathobiology and Laboratory Medicine, University of Toronto/Mount Sinai Hospital, Toronto, Ontario, Canada., Desai J; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia., Eriksson M; Department of Oncology, Skane University Hospital and Lund University, Lund, Sweden., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., George S; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts., Gounder MM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Gronchi A; Department of Surgery, National Cancer Institute of Milan, Milan, Italy., Gupta A; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Princess Margaret Cancer Center, Toronto, Ontario, Canada., Haas RL; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Radiotherapy, Leiden University Medical Center, Amsterdam, Netherlands., Hayes-Jardon A; Department of Surgery, the Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Hohenberger P; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Jones KB; Department of Orthopedics, University of Utah, Salt Lake City, Utah., Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK., Kasper B; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Kirsch DG; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina., Kleinerman ES; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le Cesne A; Medical Oncology, Gustave Roussy Institute, Villejuif, Ile-de-France, France., Lim J; Division of Cancer Registration and Surveillance, National Cancer Center, Ilsandong-gu, Goyang-si, Republic of Korea., Chirlaque López MD; Department of Epidemiology, Regional Health Council, Biomedical Research Institute of Murcia-Arrixaca, Murcia University, Murcia, Spain., Maestro R; Unit of Oncogenetics and Functional Oncogenomics, Aviano IRCCS Oncology Referral Center, Aviano, Italy., Marcos-Gragera R; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain., Martin Broto J; Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain., Matsuda T; National Cancer Registry Section, Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan., Mir O; Medical Oncology, Gustave Roussy Institute, Villejuif, Ile-de-France, France., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Raut CP; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Razak ARA; Princess Margaret Cancer Center, Toronto, Ontario, Canada., Reed DR; Department of Interdisciplinary Cancer Management, Moffitt Cancer Center, Tampa, Florida., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Sanfilippo RG; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy., Sbaraglia M; Department of Pathology, University Hospital of Padova, Padova, Italy., Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Strauss DC; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK., Sundby Hall K; Department of Oncology, the Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Thomas DM; Garvan Institute of Medical Research, Sydney, New South Wales, Australia., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute Amsterdam, Amsterdam, Netherlands., van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands., von Mehren M; Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Wagner AJ; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts., Wilky BA; Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado., Won YJ; Division of Cancer Registration and Surveillance, National Cancer Center, Ilsandong-gu, Goyang-si, Republic of Korea., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Dei Tos AP; Department of Pathology, University Hospital of Padova, Padova, Italy., Trama A; Evaluative Epidemiology Unit, Department of Research, National Cancer Institute of Milan, Milan, Italy.

Publikováno v: Cancer [Cancer] 2021 Aug 15; Vol. 127 (16), pp. 2934-2942. Date of Electronic Publication: 2021 Apr 28.